socalTECH

JUNE 15, 2010

Monrovia, California-based Prolacta Bioscience , the venture backed firm developing human milk fortifiers for premature infants, announced this morning that it will be donating funds to the Susan G. The firm said it will commit a minimum amount of $25,000 annually to fund programs at Komen.

Arcturus 221

Arcturus Draper Monrovia Funding 221

socalTECH

AUGUST 10, 2012

The use of human milk helps avoid serious side effects that can occur with premature infants if they use cow-based milk. Prolacta is venture backed by such companies as Health Evolution Partners, Alta Partners, DFJ Frontier, Arcturus Capital, DFJ Mercury, Funk Ventures, Phillip Capital, Gideon Hixon Fund, and Draper Associates.

Arcturus 164

Arcturus Draper Monrovia Organization 164

socalTECH

SEPTEMBER 23, 2011

Prolacta has been developing processes which process human milk, and convert that into human milk fortifier which helps prevent medical issues often encountered by feeding premature babies with cow-based fortifiers. According to Prolacta, the National Milk Bank will recruit potential breast milk donors for Prolacta. READ MORE>>.

Arcturus 166

Arcturus Draper Monrovia Capital 166

socalTECH

DECEMBER 1, 2010

Prolacta is venture backed by Alta Partners, DFJ Frontier, Arcturus Capital, DFJ Mercury, Funk Ventures, Phillip Capital, Gideon Hixon Fund, and Draper Associates L.P. READ MORE>>.

Arcturus 124

Arcturus Draper Monrovia Screening 124